Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
388.80M | 368.90M | 309.00M | 90.60M | 311.60M |
Gross Profit | ||||
134.00M | 172.80M | 140.90M | -14.60M | 147.10M |
EBIT | ||||
28.60M | 43.40M | 51.70M | -35.10M | 37.90M |
EBITDA | ||||
63.70M | 76.90M | 82.60M | -2.90M | 70.80M |
Net Income Common Stockholders | ||||
11.10M | 29.70M | 34.40M | -38.30M | 19.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
16.90M | 10.70M | 34.00M | 4.70M | 1.10M |
Total Assets | ||||
1.35B | 1.05B | 1.06B | 997.50M | 989.60M |
Total Debt | ||||
376.50M | 175.90M | 207.80M | 253.40M | 281.50M |
Net Debt | ||||
359.60M | 165.20M | 173.80M | 248.70M | 280.40M |
Total Liabilities | ||||
578.00M | 329.70M | 362.20M | 352.10M | 398.80M |
Stockholders Equity | ||||
771.60M | 724.20M | 699.70M | 645.40M | 590.80M |
Cash Flow | Free Cash Flow | |||
17.40M | 42.70M | 65.00M | -42.10M | 26.10M |
Operating Cash Flow | ||||
65.90M | 82.90M | 101.90M | -23.00M | 59.00M |
Investing Cash Flow | ||||
-199.60M | -52.30M | -14.10M | -18.70M | -67.20M |
Financing Cash Flow | ||||
132.40M | -53.90M | -58.50M | 45.30M | 800.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £43.31B | 39.28 | 21.72% | 1.86% | 6.81% | -14.09% | |
76 Outperform | £1.45B | 9.73 | 6.35% | ― | 4.27% | ― | |
74 Outperform | £302.83M | 15.97 | 4.58% | 3.37% | 2.22% | 98.79% | |
63 Neutral | £231.53M | ― | 2.70% | ― | 3.02% | 29.25% | |
63 Neutral | £683.62M | 11.86 | 16.38% | 1.94% | 3.70% | 57.10% | |
61 Neutral | £441.80M | 25.19 | 1.81% | 4.15% | 16.73% | -55.22% | |
59 Neutral | $6.44B | 11.30 | 3.27% | 4.27% | 2.37% | -21.19% |